Charles Weijer
Professor
Joint Appointment with Department of Medicine
Cross Appointment with Department of Epidemiology and Biostatistics
Bioethics, Research Ethics
BMdSc, MD Alberta; BA (Hons) MSc,
Office: Stevenson Hall 4130
Email: cweijer@uwo.ca
Website:
Charles Weijer is a bioethicist and an internationally recognized expert in research ethics. His publications on the duty of care in clinical research, the ethical analysis of study benefits and harms, and empowering communities in research have been broadly influential.
From 2008 to 2013, Dr. Weijer co-led a collaboration that produced the first international ethics guidelines for cluster randomized trials. From 2014 to 2018 he collaborated with Dr. Adrian M. Owen on a project exploring the ethics of functional neuroimaging after severe brain injury. Dr. Weijer led the writing team for the World Health Organization’s guidance on “Ethical Considerations for Health Policy and Systems Research,” published in 2019. In 2020, he served on the WHO Working Group for Guidance on Human Challenge Studies in COVID-19.
Charles’ current work explores the ethics of cluster randomized trials with a focus on the ethical challenges raised by stepped wedge and crossover designs, research in low-resource settings, and pragmatism. He leads a team of 31 ethicists, biostatisticians, trialists, and patient partners from Africa, Europe, North America, and South America who will update ethical guidance for cluster randomized trials.
Charles is also working with Dr. Marat Slessarev and an interdisciplinary team to explore the ethics of research involving imminently dying patients, and ethical issues in organ donation, including the use of normothermic regional perfusion.
Charles held the Tier 1 Canada Research Chair in Bioethics from 2005 to 2019. In 2014, he received 澳门六合彩开奖预测’s Hellmuth Prize for Achievement in Research, and, in 2016, he was elected to the Royal Society of Canada.
Selected publications
Weijer C, Grimshaw JM, Taljaard M, Binik A, Boruch R, Brehaut JC, Donner A, Eccles MP, Gallo A, McRae AD, Saginur R, Zwarenstein M. . Trials 2011; 12: 100.
Weijer C, Grimshaw JM, Eccles MP, McRae AD, White A, Brehaut JC, Taljaard M and the Ottawa Ethics of Cluster Randomized Trials Consensus Group. . PLoS Medicine 2012; 9(11): e1001346.
Weijer C, Bruni T, Gofton T, Young GB, Norton L, Peterson A, Owen AM. . Brain 2016; 139(Pt 1): 292-299.
Weijer C, Goldstein CE, Taljaard M. Clinical Trials 2018; 15(1): 21-24.
Mtande TK, Weijer C, Hosseinipour MC, Taljaard M, Matoga M, Goldstein CE, Nyambalo B, Rosenberg NE. . Journal of Medical Ethics 2019; 45(6): 388-393.
Weijer C, Taljaard M. . Journal of Medical Ethics 2020; 46(1): 31-33.
McPartlin SO, Morrison J, Rohrig A, Weijer C. British Medical Journal 2020; 371: m4258.
Weijer C, Hemming K, Phillips Hey S, Fernandez Lynch H. Clinical Trials 2021; 18(3): 371-376.
Nix HP, Weijer C, Brehaut JC, Forster D, Goldstein CE, Taljaard M. . BMJ Open 2021; 11(9): e054213.
Nix HP, Largent EA, Taljaard M, Mitchell SL, Weijer C. . JAGS: Journal of the American Geriatric Society 2023; 71(2): 588-598.
Murphy N, Weijer C, Debicki D, Laforge G, Norton L, Gofton T, Slessarev M. . Journal of Medical Ethics 2023; 49(5): 311-318.
Rid A, Feld JJ, Liang TJ, Weijer C. . Clinical Infectious Diseases 2023; 77(Supplement_3): S216-S223.
